Inoviq Ltd Net Assets

Latest as of December 2025: AU$22.26 Million AUD ≈ $15.75 Million USD

Inoviq Ltd net assets. Based on the latest financial reports, Inoviq Ltd (IIQ) has net assets worth AU$22.26 Million AUD (≈ $15.75 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$24.52 Million ≈ $17.35 Million USD) and total liabilities (AU$2.26 Million ≈ $1.60 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore IIQ shareholders equity momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$22.26 Million
% of Total Assets	90.79%
Annual Growth Rate	8.73%
5-Year Change	-42.48%
10-Year Change	489.8%
Growth Volatility	190.12

Net Assets of Inoviq Ltd (1989–2025)

Net assets of Inoviq Ltd from 1989 to 2025. This chart illustrates how Inoviq Ltd's net assets have evolved over time, based on quarterly financial data. See IIQ equity financing ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Inoviq Ltd (1989–2025)

The table below shows the annual net assets of Inoviq Ltd from 1989 to 2025. For live market cap and overall valuation, see IIQ market cap.

Year	Net Assets	Change
2025-06-30	AU$16.71 Million ≈ $11.83 Million	-16.37%
2024-06-30	AU$19.99 Million ≈ $14.14 Million	+1.89%
2023-06-30	AU$19.62 Million ≈ $13.88 Million	-30.67%
2022-06-30	AU$28.29 Million ≈ $20.02 Million	-2.63%
2021-06-30	AU$29.06 Million ≈ $20.56 Million	+348.74%
2020-06-30	AU$6.48 Million ≈ $4.58 Million	-9.24%
2019-06-30	AU$7.13 Million ≈ $5.05 Million	+531.12%
2018-06-30	AU$1.13 Million ≈ $799.89K	+338.28%
2017-06-30	AU$257.94K ≈ $182.51K	-90.90%
2016-06-30	AU$2.83 Million ≈ $2.01 Million	+61.23%
2015-06-30	AU$1.76 Million ≈ $1.24 Million	+97.91%
2014-06-30	AU$888.13K ≈ $628.41K	-69.55%
2013-06-30	AU$2.92 Million ≈ $2.06 Million	-80.69%
2012-06-30	AU$15.11 Million ≈ $10.69 Million	-43.22%
2011-06-30	AU$26.60 Million ≈ $18.82 Million	+40.83%
2010-06-30	AU$18.89 Million ≈ $13.37 Million	-0.72%
2009-06-30	AU$19.03 Million ≈ $13.46 Million	+235.75%
2008-06-30	AU$5.67 Million ≈ $4.01 Million	+177.26%
2007-06-30	AU$2.04 Million ≈ $1.45 Million	-81.49%
2006-06-30	AU$11.04 Million ≈ $7.81 Million	-34.59%
2005-06-30	AU$16.88 Million ≈ $11.95 Million	+506.93%
2004-06-30	AU$2.78 Million ≈ $1.97 Million	+12.01%
2003-06-30	AU$2.48 Million ≈ $1.76 Million	+6.66%
2002-06-30	AU$2.33 Million ≈ $1.65 Million	-74.39%
1999-06-30	AU$9.09 Million ≈ $6.43 Million	-16.06%
1998-06-30	AU$10.83 Million ≈ $7.67 Million	+3.73%
1997-06-30	AU$10.44 Million ≈ $7.39 Million	+1.32%
1996-06-30	AU$10.31 Million ≈ $7.29 Million	+4.18%
1995-06-30	AU$9.89 Million ≈ $7.00 Million	+1.75%
1994-06-30	AU$9.72 Million ≈ $6.88 Million	+503.66%
1993-06-30	AU$1.61 Million ≈ $1.14 Million	+463.29%
1992-06-30	AU$286.00K ≈ $202.36K	+1343.48%
1991-06-30	AU$-23.00K ≈ $-16.27K	-109.16%
1990-06-30	AU$251.00K ≈ $177.60K	-69.43%
1989-06-30	AU$821.00K ≈ $580.91K	--

Equity Component Analysis

This analysis shows how different components contribute to Inoviq Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 5515796800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Inoviq Ltd Net Assets Breakdown (June 2025)

Inoviq Ltd net assets breakdown by equity component as of June 2025.

Component	Amount	Percentage
Common Stock	AU$78.05 Million	466.96%
Other Comprehensive Income	AU$1.66 Million	9.96%
Other Components	AU$1.00	0.00%
Total Equity	AU$16.71 Million	100.00%

Inoviq Ltd Competitors by Market Cap

The table below lists competitors of Inoviq Ltd ranked by their market capitalization.

Company	Market Cap
Bionano Genomics Inc NASDAQ:BNGO	$12.95 Million
Riversgold Ltd AU:RGL	$12.96 Million
Managepay Systems Bhd KLSE:0156	$12.96 Million
Tellusgruppen AB ST:TELLUS	$12.96 Million
Thunderful Group AB ST:THUNDR	$12.95 Million
ASTORY Co.Ltd KQ:241840	$12.95 Million
Mida Leasing Public Company Limited BK:ML	$12.94 Million
Glen Burnie Bancorp NASDAQ:GLBZ	$12.94 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inoviq Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 19,986,328 to 16,714,434, a change of -3,271,894 (-16.4%).
Net loss of 6,932,280 reduced equity.
Share repurchases of 2,629,000 reduced equity.
Other comprehensive income decreased equity by 112,058.
Other factors increased equity by 6,401,444.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-6.93 Million	-41.47%
Share Repurchases	AU$2.63 Million	-15.73%
Other Comprehensive Income	AU$-112.06K	-0.67%
Other Changes	AU$6.40 Million	+38.3%
Total Change	AU$-	-16.37%

Book Value vs Market Value Analysis

This analysis compares Inoviq Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.86x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.01x to 0.86x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1989-06-30	AU$8.74	AU$0.13	x
1990-06-30	AU$2.67	AU$0.13	x
1991-06-30	AU$-0.24	AU$0.13	x
1992-06-30	AU$3.05	AU$0.13	x
1993-06-30	AU$16.20	AU$0.13	x
1994-06-30	AU$87.41	AU$0.13	x
1995-06-30	AU$48.85	AU$0.13	x
1996-06-30	AU$48.50	AU$0.13	x
1997-06-30	AU$49.13	AU$0.13	x
1998-06-30	AU$45.36	AU$0.13	x
1999-06-30	AU$37.58	AU$0.13	x
2002-06-30	AU$6.29	AU$0.13	x
2003-06-30	AU$5.04	AU$0.13	x
2004-06-30	AU$6.72	AU$0.13	x
2005-06-30	AU$18.83	AU$0.13	x
2006-06-30	AU$8.35	AU$0.13	x
2007-06-30	AU$1.30	AU$0.13	x
2008-06-30	AU$3.54	AU$0.13	x
2009-06-30	AU$8.45	AU$0.13	x
2010-06-30	AU$6.81	AU$0.13	x
2011-06-30	AU$7.94	AU$0.13	x
2012-06-30	AU$4.01	AU$0.13	x
2013-06-30	AU$0.77	AU$0.13	x
2014-06-30	AU$0.24	AU$0.13	x
2015-06-30	AU$0.40	AU$0.13	x
2016-06-30	AU$0.34	AU$0.13	x
2017-06-30	AU$0.01	AU$0.13	x
2018-06-30	AU$0.05	AU$0.13	x
2019-06-30	AU$0.21	AU$0.13	x
2020-06-30	AU$0.14	AU$0.13	x
2021-06-30	AU$0.38	AU$0.13	x
2022-06-30	AU$0.31	AU$0.13	x
2023-06-30	AU$0.21	AU$0.13	x
2024-06-30	AU$0.22	AU$0.13	x
2025-06-30	AU$0.15	AU$0.13	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inoviq Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -41.47%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -381.88%
• Asset Turnover: 0.10x
• Equity Multiplier: 1.10x
Recent ROE (-41.47%) is above the historical average (-110.84%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1989	-596.83%	0.00%	0.00x	1.22x	AU$-4.98 Million
1990	-209.96%	0.00%	0.00x	2.48x	AU$-552.10K
1991	0.00%	0.00%	0.00x	0.00x	AU$-441.70K
1992	-208.04%	0.00%	0.00x	1.29x	AU$-623.60K
1993	1.55%	0.00%	0.00x	1.45x	AU$-136.10K
1994	-4.58%	0.00%	0.00x	1.08x	AU$-1.42 Million
1995	1.71%	0.00%	0.00x	1.06x	AU$-820.50K
1996	0.13%	0.00%	0.00x	1.11x	AU$-1.02 Million
1997	1.30%	0.00%	0.00x	1.08x	AU$-908.64K
1998	-6.09%	0.00%	0.00x	1.07x	AU$-1.74 Million
1999	-17.45%	0.00%	0.00x	1.04x	AU$-2.50 Million
2002	-0.22%	-0.40%	0.43x	1.24x	AU$-236.08K
2003	0.44%	1.77%	0.23x	1.08x	AU$-236.72K
2004	-0.01%	-0.10%	0.10x	1.26x	AU$-277.37K
2005	0.01%	0.46%	0.02x	1.03x	AU$-1.69 Million
2006	-92.51%	-13150.37%	0.01x	1.14x	AU$-11.32 Million
2007	-542.39%	0.00%	0.00x	1.36x	AU$-11.29 Million
2008	55.78%	55.28%	0.93x	1.08x	AU$2.59 Million
2009	19.78%	31947.04%	0.00x	1.05x	AU$1.86 Million
2010	-8.50%	-878.12%	0.01x	1.04x	AU$-3.49 Million
2011	-5.86%	-30219.03%	0.00x	1.01x	AU$-4.22 Million
2012	-69.17%	-3789.93%	0.02x	1.08x	AU$-11.96 Million
2013	-360.47%	0.00%	0.00x	1.45x	AU$-10.81 Million
2014	-85.46%	0.00%	0.00x	3.18x	AU$-847.81K
2015	-169.77%	0.00%	0.00x	1.05x	AU$-3.16 Million
2016	-115.42%	0.00%	0.00x	1.16x	AU$-3.55 Million
2017	-1009.62%	-5914.81%	0.06x	2.82x	AU$-2.63 Million
2018	-160.73%	-2911.02%	0.04x	1.29x	AU$-1.93 Million
2019	-24.07%	-19670.94%	0.00x	1.07x	AU$-2.43 Million
2020	-50.25%	-3306.79%	0.01x	1.14x	AU$-3.90 Million
2021	-38.38%	-877.34%	0.04x	1.15x	AU$-14.06 Million
2022	-64.31%	-6575.01%	0.01x	1.09x	AU$-21.03 Million
2023	-45.72%	-2252.43%	0.02x	1.10x	AU$-10.93 Million
2024	-32.79%	-1224.78%	0.02x	1.09x	AU$-8.55 Million
2025	-41.47%	-381.88%	0.10x	1.10x	AU$-8.60 Million

Industry Comparison

This section compares Inoviq Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $244,146,972
Average return on equity (ROE) among peers: -24.65%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Inoviq Ltd (IIQ)	AU$22.26 Million	-596.83%	0.10x	$12.95 Million
Australian Clinical Labs Ltd (ACL)	$27.42 Million	-38.38%	4.60x	$360.33 Million
Bcal Diagnostics Ltd (BDX)	$8.59 Million	-74.52%	0.43x	$16.70 Million
Cryosite Ltd (CTE)	$4.69 Million	7.13%	0.84x	$42.13 Million
Genetic Signatures Ltd (GSS)	$4.68 Million	-64.67%	0.27x	$11.57 Million
Genetic Technologies Ltd (GTG)	$31.14 Million	-28.34%	0.06x	$4.01 Million
Healius Ltd (HLS)	$1.86 Billion	2.35%	1.04x	$269.75 Million
Imagion Biosystems Ltd (IBX)	$-3.79 Million	0.00%	0.00x	$1.74 Million
Integral Diagnostics Ltd (IDX)	$254.74 Million	12.27%	1.57x	$448.58 Million
Microba Life Sciences Ltd (MAP)	$12.56 Million	-37.70%	0.11x	$15.08 Million

About Inoviq Ltd

AU:IIQ Australia Diagnostics & Research

Market Cap

$12.95 Million

AU$18.30 Million AUD

Market Cap Rank

#26256 Global

#1170 in Australia

Share Price

AU$0.13

Change (1 day)

+0.00%

52-Week Range

AU$0.13 - AU$0.55

All Time High

AU$4.10